Leiden, Netherlands

Ericus Anna Leonardus Biessen

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ericus Anna Leonardus Biessen: Innovator in Cardiac Event Biomarkers

Introduction

Ericus Anna Leonardus Biessen is a notable inventor based in Leiden, Netherlands. He has made significant contributions to the field of cardiovascular research, particularly in identifying biomarkers for cardiac events. With a total of 2 patents, his work has the potential to impact therapeutic strategies for cardiovascular diseases.

Latest Patents

Biessen's latest patents focus on future cardiac event biomarkers, specifically CCL3, CCL5, and CCL18. These inventions relate to the identification of chemokine biomarkers that are predictive of future acute coronary syndromes, including unstable angina pectoris (UAP). His research not only identifies these biomarkers but also highlights particular chemokines as potential therapeutic targets for intervention in cardiovascular diseases.

Career Highlights

Throughout his career, Biessen has been associated with prestigious institutions such as Universiteit Leiden and Academisch Ziekenhuis Leiden. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Some of his notable coworkers include Theodorus Josephus Cornelis Van Berkel and Adriaan Otto Kraaijeveld. Their collaborative efforts have further advanced the understanding of cardiovascular health and disease.

Conclusion

Ericus Anna Leonardus Biessen's innovative work in identifying cardiac event biomarkers positions him as a key figure in cardiovascular research. His contributions have the potential to lead to significant advancements in therapeutic interventions for heart diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…